XML 22 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 319,589 $ 188,657
Investment securities, available-for-sale 436,404 250,208
Accounts receivable, net 98,739 98,267
Interest and other receivables 5,956 4,083
Inventory 21,949 35,819
Prepaid expenses 55,681 39,091
Total current assets 938,318 616,125
Property and equipment, net 4,215 4,612
Operating lease right-of-use assets 46,571 51,855
Intangible assets, net 119,782 65,490
Restricted cash 8,770 5,770
Long-term inventory 69,741 4,628
Other assets 359 476
Total assets 1,187,756 748,956
Liabilities and stockholders’ equity    
Accounts payable 16,192 17,543
Accrued liabilities 378,678 236,711
Total current liabilities 394,870 254,254
Operating lease liabilities 42,037 47,800
Other long-term liabilities 18,056 15,147
Total liabilities 454,963 317,201
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at December 31, 2024 and 2023; no shares issued and outstanding at December 31, 2024 and 2023 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at December 31, 2024 and 2023; 164,650,219 shares and 162,064,872 shares issued and outstanding at December 31, 2024 and 2023, respectively 16 16
Additional paid-in capital 2,936,871 2,862,552
Accumulated deficit (2,204,386) (2,430,837)
Accumulated other comprehensive income 292 24
Total stockholders’ equity 732,793 431,755
Total liabilities and stockholders’ equity $ 1,187,756 $ 748,956